• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

failed trials

Darts failing to hit bullseye
Biotech

2025's top 10 clinical trial flops

Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025.
James Waldron , Nick Paul Taylor Feb 9, 2026 3:00am
Comedy and tragedy masks on red curtain background

Amgen eyes lupus redemption while cancer candidate struggles

Feb 4, 2026 6:10am
Sanofi

Sanofi GCS inhibitor fails ph. 3 Fabry trial but wins in Gaucher

Feb 2, 2026 5:46am
Curtains closing on an empty stage

Pulmocide pulls ph. 3 antifungal trial over mortality rate

Jan 7, 2026 10:57am
road closed construction sign

Neuro biotech Nido closes after 5 years

Jan 2, 2026 10:24am
Golfer devastated after just barely missing a putt

Ultragenyx plans cost-cutting push after flunking phase 3 trials

Jan 2, 2026 5:37am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings